Cytokinetics | CYTK - Selling And Administration Expenses

Stock Price
60.06
Daily Change
0.06 0.10%
Monthly
-9.85%
Yearly
35.39%
Q1 Forecast
58.25

Cytokinetics reported $91.72M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Acadia Pharmaceuticals USD 146.73M 21.82M Dec/2025
Amgen USD 1.94B 237M Dec/2025
Arca Biopharma USD 5.16M 346K Mar/2025
Bayer EUR 4.05B 647M Dec/2025
Biogen USD 545.2M 38.6M Sep/2025
Brainstorm Cell Therapeutics USD 1.78M 319K Mar/2025
Bristol-Myers Squibb USD 2.18B 392M Dec/2025
Capricor Therapeutics USD 5.88M 1.6M Mar/2025
Cytokinetics USD 91.72M 67.02M Dec/2025
Eisai JPY 111.72B 7.86B Dec/2025
Eli Lilly USD 3.13B 391.3M Dec/2025
Exelixis USD 123.02M 19.9M Dec/2025
Geron USD 41.67M 2.67M Dec/2025
Halozyme Therapeutics USD 64.64M 27.11M Dec/2025
Ionis Pharmaceuticals USD 130M 43.43M Dec/2025
Ligand Pharmaceuticals USD 28.45M 8.27M Sep/2025
Merck USD 2.85B 215M Dec/2025
Novartis USD 3.31B 134M Sep/2025
Pfizer USD 4.08B 894M Dec/2025
Regeneron Pharmaceuticals USD 775M 117.2M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.75B 455M Dec/2025